Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institute on Deafness and Other Communication Disorders (F32DC013934, R21DC017804)
National Institute of Child Health and Human Development (R03HD098291, R01HD024356, U54HD079124)
National Institute of Mental Health (R01MH107573)
National Institutes of Health (P50HD103526)
- License Information
-
More Information
Article History
Accepted: 10 March 2021
First Online: 4 April 2021
Declarations
:
: Leonard Abbeduto has received funding to develop and implement outcome measures for clinical trials from F. Hoffman-LaRoche, Ltd., Roche TCRC, Inc., and Neuren Pharmaceuticals Limited, Inc. No other authors have conflicts or financial disclosures to declare. Angela John Thurman has received funding to develop and implement outcome measures from Fulcrum Therapeutics.
: All procedures were performed in accordance with the standards laid out by the Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Boards of the University of South Carolina and the University of California Davis Health. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained for all participants included in the study.
